Sangeeta Goswami
The University of Texas MD Anderson Cancer Center
ORCID: 0000-0001-9201-4503Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy”.
Sangeeta Goswami, Peter F. Thall, Xuemei Wang, Ying Yuan, Eric Jonasch +21 more
Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer Gantchev, Sonali Jindal +71 more
Jianjun Gao, Sreyashi Basu, Daniel D. Shapiro, José A. Karam, Rebecca S. Tidwell +22 more
Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer Gantchev, Sonali Jindal +44 more
Saifudeen Abdelrahim, Majd Al Shaarani, Huifang Lu, Raisa Ahmad, Sangeeta Goswami +2 more
Omar Alhalabi, Sangeeta Goswami, Padmanee Sharma, Kristen E. Pauken
Shelley M. Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Macaluso +12 more